Sylvia Regalla
Internal Medicine · Getzville, NYNPI 1558404509
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations.
Across 96 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$263
- Vanda Pharmaceuticals Inc.$239
- Novo Nordisk$138
- Collegium Pharmaceutical, Inc.$127
- Scilex Pharmaceuticals Inc.$112
- Lilly USA, LLC$96
- plus $863 from 28 others
What the payments were for
- Food & beverage$1,838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $263 |
| Vanda Pharmaceuticals Inc. | 11 | $239 |
| Novo Nordisk | 2 | $138 |
| Collegium Pharmaceutical, Inc. | 7 | $127 |
| Scilex Pharmaceuticals Inc. | 8 | $112 |
| Lilly USA, LLC | 6 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| Johnson & Johnson | 4 | $72 |
| Amgen | 4 | $63 |
| GSK | 3 | $58 |
| Azurity Pharmaceuticals, Inc. | 3 | $48 |
| Biocryst US Sales Co., LLC | 3 | $46 |
| UCB, Inc. | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Sobi, Inc | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Ionis Pharmaceuticals, Inc. | 1 | $28 |
| Si-bone, Inc. | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Virtus Pharmaceuticals LLC | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 2 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $21 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $13 |
| MDD US Operations, LLC | 1 | $12 |
| Promius Pharma LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,838 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 19 | $1,748 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Getzville
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.